ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,108, issued on May 12, was assigned to New York University (New York) and PureTech LYT Inc. (Boston).

"Anti-galectin-9 antibodies and uses thereof" was invented by Shohei Koide (New York), George Miller (Englewood, N.J.), Akiko Koide (New York), Linxiao Chen (Doylestown, Pa.), Eric Elenko (Boston), Aleksandra Filipovic (London) and Joseph Bolen (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are anti-Galectin-9 antibodies and methods of using such for inhibiting a signaling pathway mediated by Galectin-9 or eliminating pathologic cells expressing Galectin-9. Such anti-Galectin-9 antibodies may also be used to diagnose and/or t...